Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk

Tommaso Piccoli, Chiara Cupidi, Maria Stefania Spagnuolo, Bernardetta Maresca, Albino Carrizzo, Valeria La Marca, Luisa Cigliano, Carlo Veronesi, Raffaele Giovanni Maletta, Paolo Abrescia, Amalia Cecilia Bruni

Risultato della ricerca: Article

15 Citazioni (Scopus)

Abstract

Beta-amyloid accumulation in brain is a driving force for Alzheimer's disease pathogenesis. Apolipoprotein E (ApoE) represents a critical player in beta-amyloid homeostasis, but its role in disease progression is controversial. We previously reported that the acute-phase protein haptoglobin binds ApoE and impairs its function in cholesterol homeostasis. The major aims of this study were to characterize the binding of haptoglobin to beta-amyloid, and to evaluate whether haptoglobin affects ApoE binding to beta-amyloid. Haptoglobin is here reported to form a complex with beta-amyloid as shown by immunoblotting experiments with purified proteins, or by its immunoprecipitation in brain tissues from patients with Alzheimer's disease. The interaction between ApoE and beta-amyloid was previously shown to be crucial for limiting beta-amyloid neurotoxicity and for promoting its clearance. We demonstrate that haptoglobin, rather than impairing ApoE binding to beta-amyloid, promotes to a different extent the formation of the complex between beta-amyloid and ApoE2 or ApoE3 or ApoE4. Our data suggest that haptoglobin and ApoE functions in brain should be evaluated taking into account their mutual interaction with beta-amyloid. Hence, the risk of developing Alzheimer's disease might not only be linked to the different ApoE isoforms, but also rely on the level of critical ligands, such as haptoglobin.
Lingua originaleEnglish
pagine (da-a)837-847
Numero di pagine11
RivistaACS Chemical Neuroscience
Volume9
Stato di pubblicazionePublished - 2014

Fingerprint

Haptoglobins
Apolipoproteins
Crosstalk
Amyloid
Apolipoproteins E
Brain
Alzheimer Disease
Homeostasis
Apolipoprotein E2
Apolipoprotein E3
Apolipoprotein E4
Acute-Phase Proteins
Immunoprecipitation
Immunoblotting
Disease Progression
Protein Isoforms
Cholesterol
Tissue
Ligands

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cita questo

Piccoli, T., Cupidi, C., Spagnuolo, M. S., Maresca, B., Carrizzo, A., La Marca, V., ... Bruni, A. C. (2014). Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk. ACS Chemical Neuroscience, 9, 837-847.

Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk. / Piccoli, Tommaso; Cupidi, Chiara; Spagnuolo, Maria Stefania; Maresca, Bernardetta; Carrizzo, Albino; La Marca, Valeria; Cigliano, Luisa; Veronesi, Carlo; Maletta, Raffaele Giovanni; Abrescia, Paolo; Bruni, Amalia Cecilia.

In: ACS Chemical Neuroscience, Vol. 9, 2014, pag. 837-847.

Risultato della ricerca: Article

Piccoli, T, Cupidi, C, Spagnuolo, MS, Maresca, B, Carrizzo, A, La Marca, V, Cigliano, L, Veronesi, C, Maletta, RG, Abrescia, P & Bruni, AC 2014, 'Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk', ACS Chemical Neuroscience, vol. 9, pagg. 837-847.
Piccoli T, Cupidi C, Spagnuolo MS, Maresca B, Carrizzo A, La Marca V e altri. Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk. ACS Chemical Neuroscience. 2014;9:837-847.
Piccoli, Tommaso ; Cupidi, Chiara ; Spagnuolo, Maria Stefania ; Maresca, Bernardetta ; Carrizzo, Albino ; La Marca, Valeria ; Cigliano, Luisa ; Veronesi, Carlo ; Maletta, Raffaele Giovanni ; Abrescia, Paolo ; Bruni, Amalia Cecilia. / Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk. In: ACS Chemical Neuroscience. 2014 ; Vol. 9. pagg. 837-847.
@article{b9ddcb3faeb34e33a3f577c7a9e9f23c,
title = "Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk",
abstract = "Beta-amyloid accumulation in brain is a driving force for Alzheimer's disease pathogenesis. Apolipoprotein E (ApoE) represents a critical player in beta-amyloid homeostasis, but its role in disease progression is controversial. We previously reported that the acute-phase protein haptoglobin binds ApoE and impairs its function in cholesterol homeostasis. The major aims of this study were to characterize the binding of haptoglobin to beta-amyloid, and to evaluate whether haptoglobin affects ApoE binding to beta-amyloid. Haptoglobin is here reported to form a complex with beta-amyloid as shown by immunoblotting experiments with purified proteins, or by its immunoprecipitation in brain tissues from patients with Alzheimer's disease. The interaction between ApoE and beta-amyloid was previously shown to be crucial for limiting beta-amyloid neurotoxicity and for promoting its clearance. We demonstrate that haptoglobin, rather than impairing ApoE binding to beta-amyloid, promotes to a different extent the formation of the complex between beta-amyloid and ApoE2 or ApoE3 or ApoE4. Our data suggest that haptoglobin and ApoE functions in brain should be evaluated taking into account their mutual interaction with beta-amyloid. Hence, the risk of developing Alzheimer's disease might not only be linked to the different ApoE isoforms, but also rely on the level of critical ligands, such as haptoglobin.",
author = "Tommaso Piccoli and Chiara Cupidi and Spagnuolo, {Maria Stefania} and Bernardetta Maresca and Albino Carrizzo and {La Marca}, Valeria and Luisa Cigliano and Carlo Veronesi and Maletta, {Raffaele Giovanni} and Paolo Abrescia and Bruni, {Amalia Cecilia}",
year = "2014",
language = "English",
volume = "9",
pages = "837--847",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Haptoglobin interacts with apolipoprotein e and Beta-amyloid and influences their crosstalk

AU - Piccoli, Tommaso

AU - Cupidi, Chiara

AU - Spagnuolo, Maria Stefania

AU - Maresca, Bernardetta

AU - Carrizzo, Albino

AU - La Marca, Valeria

AU - Cigliano, Luisa

AU - Veronesi, Carlo

AU - Maletta, Raffaele Giovanni

AU - Abrescia, Paolo

AU - Bruni, Amalia Cecilia

PY - 2014

Y1 - 2014

N2 - Beta-amyloid accumulation in brain is a driving force for Alzheimer's disease pathogenesis. Apolipoprotein E (ApoE) represents a critical player in beta-amyloid homeostasis, but its role in disease progression is controversial. We previously reported that the acute-phase protein haptoglobin binds ApoE and impairs its function in cholesterol homeostasis. The major aims of this study were to characterize the binding of haptoglobin to beta-amyloid, and to evaluate whether haptoglobin affects ApoE binding to beta-amyloid. Haptoglobin is here reported to form a complex with beta-amyloid as shown by immunoblotting experiments with purified proteins, or by its immunoprecipitation in brain tissues from patients with Alzheimer's disease. The interaction between ApoE and beta-amyloid was previously shown to be crucial for limiting beta-amyloid neurotoxicity and for promoting its clearance. We demonstrate that haptoglobin, rather than impairing ApoE binding to beta-amyloid, promotes to a different extent the formation of the complex between beta-amyloid and ApoE2 or ApoE3 or ApoE4. Our data suggest that haptoglobin and ApoE functions in brain should be evaluated taking into account their mutual interaction with beta-amyloid. Hence, the risk of developing Alzheimer's disease might not only be linked to the different ApoE isoforms, but also rely on the level of critical ligands, such as haptoglobin.

AB - Beta-amyloid accumulation in brain is a driving force for Alzheimer's disease pathogenesis. Apolipoprotein E (ApoE) represents a critical player in beta-amyloid homeostasis, but its role in disease progression is controversial. We previously reported that the acute-phase protein haptoglobin binds ApoE and impairs its function in cholesterol homeostasis. The major aims of this study were to characterize the binding of haptoglobin to beta-amyloid, and to evaluate whether haptoglobin affects ApoE binding to beta-amyloid. Haptoglobin is here reported to form a complex with beta-amyloid as shown by immunoblotting experiments with purified proteins, or by its immunoprecipitation in brain tissues from patients with Alzheimer's disease. The interaction between ApoE and beta-amyloid was previously shown to be crucial for limiting beta-amyloid neurotoxicity and for promoting its clearance. We demonstrate that haptoglobin, rather than impairing ApoE binding to beta-amyloid, promotes to a different extent the formation of the complex between beta-amyloid and ApoE2 or ApoE3 or ApoE4. Our data suggest that haptoglobin and ApoE functions in brain should be evaluated taking into account their mutual interaction with beta-amyloid. Hence, the risk of developing Alzheimer's disease might not only be linked to the different ApoE isoforms, but also rely on the level of critical ligands, such as haptoglobin.

UR - http://hdl.handle.net/10447/103796

UR - http://pubs.acs.org/doi/abs/10.1021/cn500099f

M3 - Article

VL - 9

SP - 837

EP - 847

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

ER -